Corline Biomedical Stock

Corline Biomedical P/B

The P/B (Price-to-Book Ratio) of Corline Biomedical (CLBIO.ST) as of Aug 11, 2026 is 4.43. In the previous year, P/B (Price-to-Book Ratio) was 4.77 — a change of -7.30% (lower).

P/B

4.43

YoY

-7.30%

Last updated:

P/B (Price-to-Book Ratio) of Corline Biomedical is 2026 4.43 . P/B (Price-to-Book Ratio) of Corline Biomedical was 2025 4.77 . It decreases by -7.30% lower compared to the previous year.
Access this data via the Eulerpool API

Corline Biomedical Stock analysis

What does Corline Biomedical do? Corline Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corline Biomedical stock

P/B (Price-to-Book Ratio) of Corline Biomedical is 4.43 in 2026.

P/B (Price-to-Book Ratio) of Corline Biomedical changed from 4.77 to 4.43, representing a -7.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Corline Biomedical since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Corline Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Corline Biomedical

All Key Metrics — Corline Biomedical